BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO
Mahmoud Mahmoudian, Ph.D.,FRSC, Joins BioEclipse Board; Biopharmaceutical Industry Veteran with Proven Track Record in R&D, Venture Investments, and Business Development Stephen Ghiglieri, Managing Director at Danforth Advisors, to Serve as Interim CFO MOUNTAIN VIEW, Calif., Jan. 26, 2022 /PRNewswire/ -- BioEclipse Therapeutics™ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for developing...